These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 15797363)

  • 1. Follow-up of 28 HCMV seropositive renal-transplant recipients: comparison of clinical, biological and virological parameters in the groups of treated versus untreated infected patients.
    Kamar N; Mengelle C; Yahyaoui S; Sandres-Sauné K; Durand D; Izopet J; Rostaing L
    J Clin Virol; 2005 May; 33(1):35-42. PubMed ID: 15797363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring transplant patients for human cytomegalovirus: Diagnostic update.
    Gerna G; Lilleri D
    Herpes; 2006 May; 13(1):4-11. PubMed ID: 16732996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of HCMV DNA load in whole blood of renal transplant patients using real-time PCR assay.
    Gouarin S; Vabret A; Gault E; Petitjean J; Regeasse A; Hurault de Ligny B; Freymuth F
    J Clin Virol; 2004 Mar; 29(3):194-201. PubMed ID: 14962789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring HCMV infection with quantitative real-time PCR in HCMV-positive orthotopic liver transplant recipients, and predictive factors for treatment of the first episode of HCMV viremia.
    Pillet A; Mengelle C; Basse G; Ribes D; Kamar N; Muscari F; Lavayssière L; Suc B; Esposito L; Peron JM; Rostaing L
    Transplant Proc; 2006 Sep; 38(7):2335-8. PubMed ID: 16980083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection of human cytomegalovirus infection by FQ-PCR technique and its application in the diagnosis and treatment of HCMV infected children].
    Chen F; He Z; Pan S; Ning F; Wang Q; Xiao Z
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Jun; 16(2):187-90. PubMed ID: 12196838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring human cytomegalovirus (HCMV) in HCMV-seropositive orthotopic liver-transplant recipients by means of quantitative real-time polymerase chain reaction.
    Mengelle C; Abravanel-Legrand F; Kamar N; Alain S; Basse G; Pillet A; Lavayssière L; Suc B; Izopet J; Rostaing L
    Exp Clin Transplant; 2006 Dec; 4(2):537-43. PubMed ID: 17238855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative PCR in the diagnosis of CMV infection and in the monitoring of viral load during the antiviral treatment in renal transplant patients.
    Piiparinen H; Helanterä I; Lappalainen M; Suni J; Koskinen P; Grönhagen-Riska C; Lautenschlager I
    J Med Virol; 2005 Jul; 76(3):367-72. PubMed ID: 15902704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients.
    Lilleri D; Baldanti F; Gatti M; Rovida F; Dossena L; De Grazia S; Torsellini M; Gerna G
    J Med Virol; 2004 Jul; 73(3):412-8. PubMed ID: 15170637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rising antigenemia levels may be misleading in pre-emptive therapy of human cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients.
    Gerna G; Lilleri D; Zecca M; Alessandrino EP; Baldanti F; Revello MG; Locatelli F
    Haematologica; 2005 Apr; 90(4):526-33. PubMed ID: 15820949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Quantitative real-time PCR--usefulness in detection and monitoring of CMV infection after hematopeietic stem cells transplant].
    Grabarczyk P; Brojer E; Nasiłowska B; Mariańska B
    Pol Merkur Lekarski; 2006 Sep; 21(123):227-31. PubMed ID: 17163182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of antigenemia assay and semiquantitative polymerase chain reaction test for monitoring active cytomegalovirus infection in allogeneic hematopoietic cell transplant recipients.
    Pajand O; Ziyaeyan M; Mousavi S; Fatolahzadeh B; Hojabri Z; Bahador A; Abdossamadi Z
    Exp Clin Transplant; 2008 Jun; 6(2):149-54. PubMed ID: 18816243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and monitoring of human cytomegalovirus infection in bone marrow transplant recipients by quantitative competitive PCR.
    Ziyaeyan M; Sabahi F; Alborzi A; Mahboudi F; Kazemnejad A; Ramzi M; Moravej A; Jaberi MM
    Exp Clin Transplant; 2006 Jun; 4(1):470-4. PubMed ID: 16827646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saliva as a source of HCMV DNA in allogeneic stem cell transplantation patients.
    Correia-Silva JF; Bruna-Romero O; Resende RG; Miranda LP; Oliveira FE; Costa FO; Xavier SG; Figueiredo-Neves SP; Almeida HC; Bittencourt H; Gomez RS
    Oral Dis; 2010 Mar; 16(2):210-6. PubMed ID: 20374507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the NucliSens CMV pp67 assay for detection and monitoring of human cytomegalovirus infection after allogeneic stem cell transplantation.
    Hebart H; Rudolph T; Loeffler J; Middeldorp J; Ljubicic T; Jahn G; Einsele H
    Bone Marrow Transplant; 2002 Aug; 30(3):181-7. PubMed ID: 12189537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of cytomegalovirus DNAaemia versus pp65-antigenaemia cutoff for guiding preemptive therapy in transplant recipients: a randomized study.
    Gerna G; Baldanti F; Torsellini M; Minoli L; Viganò M; Oggionnis T; Rampino T; Castiglioni B; Goglio A; Colledan M; Mammana C; Nozza F; Daniele L;
    Antivir Ther; 2007; 12(1):63-72. PubMed ID: 17503749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance of cytomegalovirus (CMV) DNAemia in pediatric allogeneic stem cell transplantation: incidence and outcome of CMV infection and disease.
    Bordon V; Bravo S; Van Renterghem L; de Moerloose B; Benoit Y; Laureys G; Dhooge C
    Transpl Infect Dis; 2008 Feb; 10(1):19-23. PubMed ID: 17511814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of early cytomegalovirus infection and disease in renal transplant recipients.
    Sagedal S; Hartmann A; Rollag H
    Clin Microbiol Infect; 2005 Jul; 11(7):518-30. PubMed ID: 15966969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a novel real-time PCR system for cytomegalovirus DNA quantitation on whole blood and correlation with pp65-antigen test in guiding pre-emptive antiviral treatment.
    Allice T; Cerutti F; Pittaluga F; Varetto S; Franchello A; Salizzoni M; Ghisetti V
    J Virol Methods; 2008 Mar; 148(1-2):9-16. PubMed ID: 18045702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UL40 human cytomegalovirus variability evolution patterns over time in renal transplant recipients.
    Garrigue I; Faure-Della Corte M; Magnin N; Recordon-Pinson P; Couzi L; Lebrette ME; Schrive MH; Roncin L; Taupin JL; Déchanet-Merville J; Fleury H; Lafon ME
    Transplantation; 2008 Sep; 86(6):826-35. PubMed ID: 18813108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Qualitative detection of human cytomegalovirus DNA in the plasma of bone marrow transplant recipients: value as a predictor of disease progression.
    Behzad-Behbahani A; Ehsanipour F; Alborzi A; Nourani H; Ramzi M; Rasoli M
    Exp Clin Transplant; 2004 Jun; 2(1):196-200. PubMed ID: 15859928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.